Search alternatives:
ppm decrease » _ decrease (Expand Search), pa decreased (Expand Search), 026 decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ppm decrease » _ decrease (Expand Search), pa decreased (Expand Search), 026 decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
561
C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion
Published 2021“…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”
-
562
S1 Data -
Published 2024“…Specifically, total immune cells (CD45+) decrease at days 2 and 5 following IR, macrophages (F4/80+CD11b+) decrease at day 2 and 5 and increase at day 30, while neutrophils (Ly6G+CD11b+) significantly increase at day 30 following IR. …”
-
563
SARS-CoV-2 genome sequencing metrics.
Published 2025“…We investigated viral and host factors, including vaccination status, that were associated with SARS-CoV-2 disease severity in a setting with low vaccination rates. …”
-
564
SARS-CoV-2 variants by vaccination status.
Published 2025“…We investigated viral and host factors, including vaccination status, that were associated with SARS-CoV-2 disease severity in a setting with low vaccination rates. …”
-
565
-
566
-
567
-
568
Room-Temperature Photoferroelectrics Semiconductor Driven by the Interlayer Confinement Effect
Published 2024Subjects: -
569
Room-Temperature Photoferroelectrics Semiconductor Driven by the Interlayer Confinement Effect
Published 2024Subjects: -
570
TGFβ1 and COL1A1 expression was decreased and RASAL1 expression was increased by Western blotting in NTM cells under both normoxic and hypoxic conditions.
Published 2016“…We found that COL1A1 protein was decreased in the presence of 5-aza. …”
-
571
Top 5 templates of CNN1 isoform 2 by PHYRE2 tool.
Published 2023“…<div><p>Prematurity is the foremost cause of death in children under 5 years of age. Genetics contributes to 25–40% of all preterm births (PTB) yet we still need to identify specific targets for intervention based on genetic pathways. …”
-
572
-
573
-
574
R346K Mutation in the <i>Mu</i> Variant of SARS-CoV‑2 Alters the Interactions with Monoclonal Antibodies from Class 2: A Free Energy Perturbation Study
Published 2022“…The <i>Mu</i> variant of SARS-CoV-2 has been recently classified as a variant of interest (VOI) by the World Health Organization (WHO) but limited data are available at the moment. …”
-
575
R346K Mutation in the <i>Mu</i> Variant of SARS-CoV‑2 Alters the Interactions with Monoclonal Antibodies from Class 2: A Free Energy Perturbation Study
Published 2022“…The <i>Mu</i> variant of SARS-CoV-2 has been recently classified as a variant of interest (VOI) by the World Health Organization (WHO) but limited data are available at the moment. …”
-
576
-
577
-
578
-
579
A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity
Published 2019“…In patients with abnormal C5, basal levels of sC5b-9 and C5a were increased while activities of the CP and of the CP C5-convertase, the immediate C5-upstream complex, were decreased compared to NC and to patients with normal C5. …”
-
580
Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera
Published 2023“…After the discovery of a mutation in the Janus kinase 2 (<i>JAK</i>2<sup>V617F</sup>), JAK2 inhibitors have been tested as second-line therapies. …”